Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery

International Journal of Pharmaceutics

Volumn 136, Issue 1-2, 1996, Pages 117-139

  Rouge, N ^a   Buri, P ^a   Doelker, E ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Absorption mechanisms; Absorption site; Absorption window; Dosage forms; Gastrointestinal tract; Site specific delivery

Indexed keywords

ACRIVASTINE; ALLOPURINOL; BENAZEPRIL; BIDISOMIDE; CAPTOPRIL; CIPROFLOXACIN; CYCLOSPORIN; DESMOPRESSIN; DICLOFENAC; DIGOXIN; FUROSEMIDE; GEPIRONE; GLIBENCLAMIDE; GRISEOFULVIN; LEVODOPA; METOPROLOL; NICARDIPINE; NITRENDIPINE; OCTREOTIDE; OXPRENOLOL; PARACETAMOL; PIRETANIDE; PRAVASTATIN; RANITIDINE; SUMATRIPTAN; THEOPHYLLINE; UNINDEXED DRUG;

DIFFUSION; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG METABOLISM; DRUG TARGETING; GASTROINTESTINAL ABSORPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH PH;

EID: 0029953050     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)85200-8     Document Type: Article

References (181)

1. Adson, A., Raub, T.J., Burton, P.S., Barsuhn, C.L., Hilgers, A.R., Audus, K.L. and Ho, N.F.H., Quantitative approaches to delineate paracellular diffusion in cultures epithelial cell monolayers. J. Pharm. Sci., 83 (1994) 1529-1536.
2. Amidon, G.L., Kou, J., Elliot, R.L. and Lightfoot, E.N., Analysis of models for determining intestinal wall permeabilities. J. Pharm. Sci., 69 (1980) 1369-1373.
3. Antonin, K.H., Other methods in studying colonie drug absorption. In Bieck, P.R. (Ed.). Colonic drug absoption and metabolism, Marcel Dekker. INC. New York, 1993, pp. 89-107.
4. Artursson, P., Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci., 79 (1990) 476-482.
5. Artursson, P., Ungell, A.L. and Löfroth, J.E., Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res., 10 (1993) 1123-1129.
6. Ashford, M., Fell, J.T., Attwood, D., Sharma, H. and Woodhead, P.L., An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int. J. Pharm., 95 (1993) 193-199.
7. Ashford, M., Fell, J., Attwood, D., Sharma, H. and Woodhead, P., Studies on pectin formulations for colonic drug delivery. J. Controlled Release, 30 (1994) 225-232.
8. Ashford, M. and Fell, J.T., Targeting drugs to the colon: delivery systems for oral administration. J. Drug Targeting, 2 (1994) 241-258.
9. Balasubramanian, R., Klein, K.B., Pittman, A.W., Liao, S.H.T., Findlay, J.W.A. and Frosolono, M.F., Pharmacokinetics of acrivastine after oral and colonie administration. J. Clin. Pharmacol., 29 (1989) 444-447.
10. Banker, G.S., Br. Patent. 1,428,426 (1973)
11. Bechgaard, H. and Christensen, F.N., Gut reaction to tablets and capsules. 2. Physiological factors and controlled-release dosage forms. Pharm. J., 229 (1982) 373-376.
12. Blanchard, J., Tang, L.M. and Earle, M.E., Reevaluation of the absorption of carbenoxolone using an in situ rat intestinal technique. J. Pharm. Sci., 79 (1990) 411-414.
13. Bohner, V., Rothen-Rutishauser, B., Perriard, J.C., Ottiger, C., Wunderli-Allenspach, H., Merkle, H.P. and Langguth, P., Paracellular transport and other mechanisms involved in intestinal peptide absorption Proc. 1st World Meeting APGI APV Budapest, (1995) 862-863.
14. Brennan, J., O'Donnell, D., Zinny, M., Jain, N., Ivashkiv, E. and Arnold, M., The comparative bioavailability of captopril after colonic infusion and oral administration in healthy volunteers. Clin. Pharmacol. Ther., 49 (1991) A131.
15. Brockmeier, D., Grigoleit, H.-G. and Leonhardt, H., Absorption of glibenclamide from different sites of the gastro-intestinal tract. Eur. J. Clin. Pharmacol., 29 (1985) 193-197.
16. Brockmeier, D., In vitro/in vivo correlation of dissolution using moments of dissolution and transit times. Acta Pharm. Technol. 32 (1986) 164-174.
17. Brockmeier, D., Grigoleit, H.-G., Heptner, H. and Meyer, B.H. Kinetics of piretanide absorption from the gastrointestinal tract. Meth. Find. Exp. Clin. Pharmacol., 8 (1986a) 731-739.
18. Brockmeier, D., Grigoleit, H.-G. and Leonhardt, H., The absorption of piretanide from the gastro-intestinal tract is site-dependent. Eur. J. Clin. Pharmacol., 30 (1986b) 79-82.
19. Brondsted, H. and Kopecek, J., Hydrogels for site-specific drug delivery to the colon: in vitro and in vivo degradation. Pharm. Res., 9 (1992) 1540-1545.
20. Cargill, R., Caldwell, L.J., Engle, K., Fix, J.A., Porter, P.A. and Gardner, C.R., Controlled gastric emptying. 1. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs. Pharm. Res., 5 (1988) 533-536.
21. Chadwick, V.S., Phillips, S.F. and Hofmann, A.F., Measurements of intestinal permeability using low molecular weight polyethylenglycols (PEG 400). Gastroenterology, 73 (1977) 247-251.
22. Chamblis, W.G., The forgotten dosage form: enteric-coated tablets. Pharm. Technol., 7(9) (1983) 124-140.
23. Chan, K.K.C., Buch, A., Glazer, R.D., John, V.A. and Barr, W.H., Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers. Pharm. Res., 11 (1994) 432-437.
24. Chiou, W.L., Effect of 'unstirred' water layer in the intestine on the rate and extent of absorption after oral absorption. Biopharm. Drug. Dispos., 15 (1994) 709-717.
25. Chungi, V.S., Dittert, L.W. and Smith, R.B., Gastrointestinal sites of furosemide absorption in rats. Int. J. Pharm., 4 (1979) 27-38.
26. Clarke, G.M., Newton, J.M. and Short, M.D., Gastrointestinal transit of pellets of different size and density. Int. J. Pharm., 100 (1993) 81-92.
27. Clarke, G.M., Newton, J.M. and Short, M.B., Comparative gastrointestinal transit of pellet systems of varying density. Int. J. Pharm., 114 (1995) 1-11.
28. Cook, C.S., Ames, G.B., Smith, M.E., Kowalski, K.G. and Karim, A., Absorption and disposition of new antiarrhythmic agent bidisomide in man. Pharm. Res., 10 (1993) 1675-1682.
29. Crevoisier, C. and Buri, P., Facteurs physico-chimiques susceptibles d'influencer l'absorption gastro-intestinale après dissolution des principes actifs. Pharm. Acta Helv., 51 (1976) 193-202.
30. d'Agay-Abensour, L., Fjellestad-Paulsen, A., Höglund, P., Ngô, Y., Paulsen, O. and Rambaud, J.C., Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in man. Eur. J. Clin. Pharmacol., 44 (1993) 473-476.
31. Davis, S.S., The design and evaluation of controlled release systems for the gastrointestinal tract. J. Controlled Release, 2 (1985) 27-38.
32. Davis, S.S., Hardy, J.G. and Fara, J.W., Transit of pharmaceutical dosage forms through the small intestine. Gut, 21 (1986a) 886-892.
33. Davis, S.S., Stockwell, A.F., Taylor, M.J., Hardy, J.G., Walley, D.R., Wilson, C.G., Bechgaard, H. and Christensen, F.N., The effect of density on gastric emptying of single- and multiple-unit dosage forms. Pharm. Res., 3 (1986b) 208-213.
34. Davis, S.S., The design and evaluation of controlled release dosage forms for oral delivery. S. T. P. Pharma, 3 (1987) 412-417.
35. Davis, S.S., Washington, N., Parr, G.D., Short, A.M., John, A.M., LLoyd, P. and Walker, S.M., Relationship between the rate of appearance of oxprenolol in the systemic ciculation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. Br. J. Clin. Pharmac., 26 (1988) 435-443.
36. Delchier, J.C., Guerret, M., Vidon, N., Dubray, C. and Lavene, D., Influence of digestive secretions and food on intestinal absorption of nicardipine. Eur. J. Clin. Pharmacol., 34 (1988) 165-171.
37. Devereux, J.E., Newton, J.M. and Short, M.B., The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol., 42 (1990) 500-501.
38. Doluisio, J.T., Billups, N.F., Dittert, L.W., Sugita, E.T. and Swintosky, J.V., Drug absorption I: an in situ rat gut technique yelding realistic absorption rates. J. Pharm. Sci., 58 (1969) 1196-1200.
39. Doluisio, J.T., Crouthamel, W.G., Tan, G.H., Swintosky, J.T. and Dittert, L.W., Drug absorption III: effect of membrane storage on the kinetics of drug absorption. J. Pharm. Sci., 59 (1970) 72-76.
40. Dressman, J.B., Bass, P., Ritschel, W.A., Friend, D.R., Rubinstein, A. and Ziv, E., Gastrointestinal parameters that influence oral medications. J. Pharm. Sci., 82 (1993) 857-872.
41. Drewe, J., Beglinger, C. and Kissel, T., The absorption site of cyclosporin in the human gastrointestinal tract. Br. J. Clin. Pharmac., 33 (1992) 39-43.
42. Duchêne, D. and Ponchel, G., Colonic administration, development of drug delivery systems, contribution of bioadhesion. S. T. P. Pharma, 3 (1993) 277-285.
43. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., McGee, J.R., Tice, T.R. and Gilley, R.M., Biodegradable microspheres as a vaccine delivery system. Mol. Immunol., 28 (1991) 287-294.
44. Erni, v.W., Held, K. and Sheth, P.R., HB-Kapsel-eine neue Arzneiform mit gesteuerter, hydrodynamischer Wirkstofffreigabe. Dtsch. Apoth. Ztg., 7 (1983) 295-299.
45. Evrard, B., Développement d'une forme galénique orale à libération prolongée en médecine vétérinaire: mise au point d'un bolus a rétention dans le reticulo-rumen chez l'ovin, Ph.D. Thesis, 1995.
46. Faigle, J.W., Drug metabolism in the colon wall and lumen. In Bieck, P.R. (Ed.), Colonic drug absorption and metabolism, Marcel Dekker, Inc. New York, 1993, pp. 29-54.
47. Fiese, G. and Perrin, J.H., Further investigations into the absorption of dextrometorphan from the rat's stomach. J. Pharm. Sci., 58 (1969) 599-601.
48. Fischer, W., Boertz, A., Davis, S.S., Khosla, R., Cawello, W., Sandrock, K. and Cordes, G., Investigation of the gastrointestinal transit and in vivo drug release of isosorbide-5-nitrate pellets. Pharm. Res., 4 (1987) 480-485.
49. Follonier, N. and Doelker, E., Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S. T. P. Pharma, 2 (1992) 141-158.
50. Fricker, G., Drewe, J., Vonderscher, J., Kissel, T. and Beglinger, C., Enterai absorption of octreotide. Br. J. Pharmacol., 105 (1992) 783-786.
51. Friedman, D.I. and Amidon, G.L., Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852. J. Pharm. Sci., 78 (1989) 995-998.
52. Friedman, D.I. and Amidon, G.L., Characterization of the intestinal transport parameters for small peptide drugs. J. Controlled Release, 13 (1990) 141-146.
53. Fuhr, U., Hoyer, J., Ritter, W. and Staib, A.H., Resorption-sunterschiede fur BAY U 3405 entlang des menschlichen Gastrointestinaltraktes. 2. Jahrestagung der Ges. f. klin. Pharmacol. e. V. (1992) (Abstract).
54. Gabus-Sannié, C. and Buri, P., Etude comparative des méthodes de détermination du volume d'eau absorbé lors de perfusion de l'intestin grêle du rat. S. T. P. Pharma, 3 (1987) 856-859.
55. Gan, L.S., Hsyu, P.M., Pritchard, J.F. and Thakker, D., Mechanism of intestinal absorption of ranitidine and ondansetron: transport across CAco-2 cell monolayers. Pharm. Res., 10 (1993) 1722-1725.
56. Gazzaniga, A., Iamartino, P., Maffione, G. and Sangalli, M.E., Oral delayed-release system for colonie specific delivery. Int. J. Pharm., 108 (1994a) 77-83.
57. Gazzaniga, A., Sangalli, M.E. and Giordano, F., Oral Chronotopic drug delivery systems: achievement of time and /or site specificity. Eur. J. Pharm. Biopharm., 40 (1994b) 246-250.
58. Gleiter, C.H., Antonin, K.H., Bieck, P., Godbillon, J., Schönleber, W. and Malchow, H., Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointestinal Endoscopy, 31 (1985) 71-73.
59. Godbillon, J., Evard, D., Vidon, N., Duval, M., Schoeller, J.P., Bernier, J.J. and Hirtz, J., Investigation of drug absorption from the gastrointestinal tract of man: III. Metoprolol in jejenum and colon. Br. J. Clin. Pharmac., 19 (1985) 113S-118S.
60. Graffner, C., Josefsson, K. and Stockman, O., Intra-intersubject variation of erythromycin absorption from singl-unit and multiple-unit enteric-coated product. Biopharm. Drug. Dispos., 1 (1986) 163-171.
61. Gramatté, T., Richter, K. and Feller, K., The absorption of paracetamol from different regions of the human small intestine. Dtsch. Ges. Pharmacol. Toxicol. abstract of the 32nd spring meeting (Mainz), (1991) 473.
62. Gramatté, T., Klotz, U. and Desoky, I.E., Small intestine absorption of ranitidine is site dependent. Abstract of the Vth World Conference on Clinical Pharmacology and Therapeutics, P-112-15 (1992).
63. Gramatté, T., Griseofulvin absorption from different sites in the human small intestine. Biopharm. Drug. Dispos., 15 (1994) 747-759.
64. Grass, G.M. and Morehead, W.T., Evidence for site-specific absorption of a novel ACE inhibitor. Pharm. Res., 6 (1989) 759-765.
65. Graul, E.H., Loew, D. and Schuster, O., Voraussetzung für die Entwicklung einer sinnvollen Retard- und Diuretikakombination. Therapiewoche, 35 (1985) 4277-4291.
66. Gröning, R. and Heun, G., Dosage forms with controlled gastrointestinal passage -studies on the absorption of nitrofuratoin. Int. J. Pharm., 56 (1989) 111-116.
67. Gundert-Remy, U., Hildebrandt, R., Stiehl, A., Weber, E., Zürcher, G. and Da Prada, M., Intestinal absorption of levodopa in man. Eur. J. Clin. Pharmacol, 25 (1983) 69-72.
68. Haeberlin, B., Nolen III, H.W., Friend, D.R. and Rubas, W., In vitro evaluation of dexamethasone-B-D-glucuronide for colon-specific drug delivery. Pharm. Res., 10 (1993) 1553-1562.
69. Hamilton, I., Rothwell, J., Archer, D. and Axon, A.T.R., Permeability of the rat small intestine to carbohydrate probe molecules. Clin. Sci., 73 (1987) 189-196.
70. Harder, S., Fuhr, U., Beermann, D. and Staib, A.H., Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. Br. J. Clin. Pharm., 30 (1990) 35-39.
71. Hardy, J.G., Evans, D.F., Zaki, I., Clark, A.G., Tonnensen, H.H. and Gamst, O.N., Evaluation of an enteric coated naproxen tablet using gamma scintigraphy and pH monitoring. Int. J. Pharm., 37 (1987) 245-250.
72. Harrigan, R.M., US Patent, 4,055,178 (1977).
73. Harris, D., Fell, J.T., Sharma, H.L. and Taylor, D.C., GI transit of potential bioadhesive formulations in man: a scintigraphic study. J. Controlled Release, 12 (1990a) 45-53.
74. Harris, D., Fell, J.T., Taylor, D.C., Lynch, J. and Sharma, H.L., GI transit potential bioadhesive systems in the rat. J. Controlled Release, 12 (1990b) 55-65.
75. Hildago, I.J., Bhatnagar, P., Lee, C.P., Miller, J., Cucullino, G. and Smith, P.L., Structural requirements for interaction with the oligopeptide transporter in CaCo-2 cells. Pharm. Res., 12 (1995) 317-319.
76. Hilton, A.K. and Deasy, P.B., In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int. J. Pharm., 86 (1992) 79-88.
77. Hirtz, J., The absorption window: fact or fiction? Pharm. Int., (1984) 175-178.
78. Ho, N.F.H., Day, J.S., Barsuhn, C.L., Burton, P.S. and Raub, T.J., Biophysical model approaches to mechanistic transepithelial studies of peptides. J. Controlled Release, 11 (1990) 3-24.
79. Ichikawa, M., Kato, T., Kawahara, M., Watanabe, S. and Kayano, M., A new multiple-unit oral floating dosage system. II: in vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J. Pharm. Sci., 80 (1991a) 1153-1156.
80. Ichikawa, M., Watanabe, S. and Miyake, Y., A new multiple-unit oral floating dosage systems, I:preparation and in vitro evaluation of floating and sustained release characteristics. J. Pharm. Sci., 80 (1991b) 1062-1065.
81. Ingani, H.M., Timmermans, J. and Moës, A.J., Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. Int. J. Pharm., 35 (1987) 157-164.
82. Inouye, K., Machida, Y., Sannan, T. and Nagai, T., Buoyant sustained release tablets based on chitosan. Drug Des. Deliv., 2 (1988) 165-175.
83. Inouye, K., Machida, Y., Sannan, T. and Nagai, T., Buoyant sustained release granules based on chitosan. Drug Des. Deliv., 4 (1989) 55-67.
84. Jobin, G., Cortot, A., Godbillon, J., Duval, M., Schoeller, J.P., Hirtz, J. and Bernier, J.J., Investigation of drug absorption from the gastrointestinal tract of man:I. Metoprolol in stomach, duodenum, and jejenum. Br. J. Clin. Pharmac., 19 (suppl 2) (1985) 97S-105S.
85. Kaniwa, N., Aoyagi, N., Ogata, H., Ejima, A., Motoyama, H. and Yasumi, H., Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans. J. Pharmacobio-Dyn., 11 (1988) 571-575.
86. Kararli, T.T., Gastrointestinal absorption of drugs. Crit. Rev. Ther. Drug Car. Syst., 6 (1989) 39-86.
87. Kawashima, Y., Niwa, T., Takeuchi, H., Hino, T. and Itoh, Y., Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Controlled Release, 16 (1991) 279-290.
88. Kayne, L.H. and Lee, D.B.N., Intestinal magnesium absorption. Miner. Electrolyte Metab., 19 (1993) 210-217.
89. Kesslhut, J.F. and Bauer, K.H., Laurinic acid dextranesters for site-specific drug deliveery to the human colon. Eur. J. Pharm. Biopharm., 40 (1994) 38 S.
90. Khosla, R. and Davis, S.S., The effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol., 39 (1987) 47-49.
91. Kim, J.S., Oberle, R.L., Krummel, D.A., Dressman, J.B. and Fleisher, D., Absorption of ACE inhibitors from small intestine and colon. J. Pharm. Sci., 83 (1994) 1350-1356.
92. Komiya, I., Park, J.Y., Kamani, A., Ho, N.F.H. and Higuchi, W.I., Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm., 4 (1980) 249-262.
93. Köhler, E., Duberow-Drewe, M., Drewe, J., Ribes, G., Loubatières-Mariani, M.M., Mazer, N., Gyr, K. and Beglinger, C., Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage. Eur. J. Clin. Pharmacol., 33 (1987) 167-171.
94. Krevsky, B., Malmud, L.S., D'ercole, F., Maurer, A.H. and Fisher, R.S., Colonic transit scintigraphy. Gastroenterology, 91 (1986) 1102-1112.
95. Langguth, P., Merkle, H.P. and Amidon, G.L., Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid. Pharm. Res., 11 (1994) 528-535.
96. Lee, S.H., Lee, M.G. and Kim, N.D., Pharmacokinetics and pharmacodynamics of bumetanide. After intravenous and oral administration to rats: absorption from various GI segments. J. Pharmacokinet. Biopharm., 22 (1994) 1-17.
97. Lee, V.H.L., Yamamoto, A. and Kompella, U.B., Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Car. Syst., 8 (1991) 91-192.
98. Lehr, C.M., Bouwstra, J.A., Kok, W., Noach, A.B.J., de Boer, A.G. and Junginger, H.E., Bioadhesion by means of specific binding of tomato lectin. Pharm. Res., 9 (1992) 547-553.
99. Levy, G. and Jusko, W.J., Factors affecting the absorption of riboflavin in man. J. Pharm. Sci., 55 (1966) 285-289.
100. Li, V.H.K., Robinson, J.R. and Lee, V.H.L., Influence of drug properties and routes of administration on the design of sustained and controlled release systems. In J.R. Robinson and V.H.L. Lee (Eds.), Controlled drug delivery: Fundamentals and applications. Marcel Dekker Inc. New York, 1987, pp. 3-79.
101. Longer, M.A., Ch'ng, H.S. and Robinson, J.R., Bioadhesive polymers as platforms for oral controlled dru delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J. Pharm. Sci., 74 (1985) 406-411.
102. Lu, H.H., Thomas, J. and Fleischer, D., Influence of D-glucose-induced water absorption on rat jejunal uptake of two passively absorbed drugs. J. Pharm. Sci., 81 (1992) 21-25.
103. Machida, Y., Inouye, K., Tokumura, T., Iwata, M. and Nagai, T., Preparation and evaluation of intragastric buoyant preparations. Drug Des. Deliv., 5 (1989) 155-161.
104. McLeod, A.D., Friend, D.R. and Tozer, T.N., Glucocorticoiddextran conjugated as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J. Pharm. Sci., 83 (1994) 1284-1288.
105. McNeill, M., Rashid, A. and Stevens, H., Dispensing device. WO90/09168 (1990).
106. Menon, A., Ritschel, A. and Sakr, A., Development and evaluation of a monolithic floating dosage form for furosemide. J. Pharm. Sci., 83 (1994) 239-245.
107. Merkle, W., Borman, D., Mania, D., Muschaweck, R. and Hropot, M., Piretanide (HOE 118) a new high ceiling salidiuretic. Eur. J. Med. Chem., 11 (1976) 399-406.
108. Michaels, A.S., US Patent, 3,786,813 (1974).
109. Michaels, A.S., Bashwa, J.D. and Zaffaroni, A., US Patent, 3,901,232 (1975).
110. Miyazaki, S., Yamaguchi, H., Yokouchi, C., Takada, M. and Hou, W.M., Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chem. Pharm. Bull., 36 (1988) 4033-4038.
111. Moës, A.J., Gastroretentive dosage forms. Crit. Rev. Ther. Drug Car. Syst., 10 (1993) 143-195.
112. Möller, H., Gastrointestinal absorption and transportkinetics. In Gundert-Remy, U. and Möller, H. (Eds.), Oral controlled release products. Wiss. Verl.-Ges. Stuttgart, 1989, pp. 117-137.
113. Mummaneni, V. and Dressman, J.B., Intestinal uptake of cimetidine and ranitidine in rats. Pharm. Res., 11 (1994) 1599-1604.
114. Müller-Lissner, S.A., Will, N., Müller-Duysing, W., Heinzel, F. and Blum, A.L., Schwimmkapseln mit langsamer Wirkstoffabgabe. Dtsch. med. Wschr., 106 (1981) 1143-1147.
115. Müller-Lissner, S.A. and Blum, A.L., The effect of specific gravity and eating on gastric emptying of slow-release capsules. N. Engl. J. Med., 304 (1981) 1365-1366.
116. Nilsson, D., Fagerholm, U. and Lennernäs, H., The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum. Pharm. Res., 11 (1994) 1540-1544.
117. Nook, T., Doelker, E. and Buri, P., Intestinal absorption kinetics of various model drugs in relation to partition coefficients. Int. J. Pharm., 43 (1988) 119-129.
118. Oberle, R.L. and Amidon, G.L., The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon. J. Pharmacokin. Biopharm., 15 (1987) 529-544.
119. Ochs, H., Bodem, G., Schäfer, P.K., Kodrat, G. and Dengler, H.J., Absorption of digoxin from the distal parts of the intestine in man. Eur. J. Clin. Pharmacol., 9 (1975) 95-97.
120. Oth, M., Franz, M., Timmermans, J. and Moës, A.J., The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res., 9 (1992) 298-302.
121. Park, G. and Mitra, A.K., Mechanism and site dependency of intestinal mucosal transport and metabolism of thymidine analogues. Pharm. Res., 9 (1992) 326-331.
122. Perrin, J.H. and Vallner, J.J., The effect of the anion on the absorption of tetracycline from the rat stomach. J. Pharm. Pharmacol., 22 (1970) 758-762.
123. Riad, L.E. and Sawchuk, R.J., Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine. Pharm. Res., 8 (1991) 1050-1055.
124. Rietbrock, S., Keller-Stanislawski, B., Thürmann, P. and Brockmeier, D., Pharmacokinetic profile of a novel slow release preparation of molsidomine. Eur. J. Clin. Pharmacol., 43 (1992) 273-276.
125. Ritschel, W.A., In vivo animal model for bioavailability assessment. S. T. P. Pharma. 3(2) (1987) 125-141.
126. Ritschel, W.A., Targeting in the gastrointestinal tract: new approaches. Meth. Find. Exp. Clin. Pharmacol., 13 (1991) 313-336.
127. Ritschel, W.A., Menon, A. and Sakr, A., Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form. Meth. Find. Exp. Clin. Pharmacol., 13 (1991) 629-636.
128. Robinson, D.H. and Mauger, J.W., Drug delivery systems. Am. J. Hosp. Pharm., 48 (1991) S14-S23.
129. Rojanasakul, Y., Wang, L.Y., Bhat, M., Glover, D.D., Malanga, C.J. and Ma, J.H.K., The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm. Res., 9 (1992) 1029-1034.
130. Rubinstein, A., Nakar, D. and Sintov, A., Chondroitin sulfate: a potential biodegradable carrier for colon-specific drug delivery. Int. J. Pharm., 84 (1992a) 141-150.
131. Rubinstein, A., Sintov, A. and Nakar, D., Colonie drug delivery: enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content. Pharm. Res., 9 (1992b) 276-278.
132. Rubinstein, A., Radai, R., Ezra, M., Pathak, S. and Rokem, J.S., In vitro evaluation of calcium pectinate colon-specific drug delivery carrier. Pharm. Res., 10 (1993) 258-263.
133. Ryde, M., Huilfeldt, B. and Petteresson, R., Relative bioavailability of olsalazine from tablets and capsules: a drug targeted for local effect in the colon. Biopharm. Drug. Dispos., 12 (1991) 233-246.
134. Rydén, T. and Jonsson, U.E., A study of the absorption of diltiazem from the distal parts of the gastrointestinal tract. Eur. J. Clin. Pharmacol., 36 (suppl) (1989) A243 (Abstract).
135. Saffran, M., Kumar, O.S., Savariar, C., Burnham, J.C., Williams, F. and Necker, D.C., A new approaches to the oral administration of insulin and other peptide drugs. Science, 233 (1986) 1081-1084.
136. Sanchez-Pico, A., Peris-Ribera, J.-E., Toledano, C., Torres-Molina, F., Casabo, V.-G., Martin-Villodre, A. and Pla-Delphina, J.M., Non-linear intestinal absorption kinetics of cefadroxil in the rat. J. Pharm. Pharmacol., 41 (1989) 179-185.
137. Sangekar, S., Vadmo, W.A., Chaudry, I., Parr, A., Beihn, R. and Digenis, G., Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int. J. Pharm., 35 (1987) 187-191.
138. Sasaki, H., Igarashi, Y., Nishida, K. and Nakamura, J., Intestinal permeability of ophthalmic B-blockers for predicting ocular permeability. J. Pharm. Sci., 83 (1994) 1335-1338.
139. Schanker, E.S., On the mechanism of absorption of drugs from the gastrointestinal tract. J. Med. Pharm. Chem., 2 (1960) 343-359.
140. Schurgers, N., Bidendijk, J., Tukker, J.J. and Crommelin, D.J.A., Compansion of four experimental techniques for studying drug absorption kinetics in the anesthetized rat in situ. J. Pharm. Sci., 75 (1986) 117-119.
141. Schuster, O., Haertel, M., Hugemann, B., Gikalov, I., Schiemann, O. and Fenner, H., Untersuchung zur klinischen pharmakokinetik von allopurinol. Arzneim. Forsch., 35 (1985) 760-765.
142. Shalaby, W.S.W., Blevins, W.E. and Park, K., In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery. J. Controlled Release, 19 (1992) 131-144.
143. Sheth, P.R. and Tossounian, J., Novel sustained release tablet formulations. US Patent, 4,167,558 (1979).
144. Sheth, P.R. and Tossounian, J., The hydrodynamically balanced system (HBS): a novel drug delivery system for oral use. Drug Dev. Ind. Pharm., 10 (1984) 313-339.
145. Sinko, P.J., Patel, N.R. and Hu, P., Site-specific oral absorption of didanosine: in situ characterization and correlation with extent of absorption in vivo. Int. J. Pharm., 109 (1994) 125-133.
146. Somogyi, A.A., Bochner, F., Hetzel, D. and Williams, D.B., Evaluation of the intestinal absorption of erythromycin in man: absolute bioavailability and comparison with enteric coated erythromycin. Pharm. Res., 12 (1995) 149-154.
147. Staib, A.H., Loew, D., Harder, S., Schuster, O. and Hugemann, B., Absorption of theophylline from different parts of the gastrointestinal tract. In Fairfax, A.J. (Ed.), Therapeutics in Respiratory Medicine, Royal Society of Medicine Services, London, 1987, pp. 51-60.
148. Staib, A.H., Ramsch, K.-D., Ahr, G., Liermann, J., Spichalsky, R. and Albrecht, W., Absorption of nitrendipine and nisoldipine along the intestine of man (HF-capsule study). Dtsch. Ges. Pharmacol. Toxicol. abstract of the 29th spring meeting (Mainz), (1988a) R125 (Abstract).
149. Staib, A.H., Woodcock, B.C., Menke, G. and Rietbrock, N., Remote control of gastrointestinal drug delivery in man. Third Conference on Drug Absorption, Conference Abstracts, (Edimburg), (1988b) 9.
150. Staib, A.H., Beermann, D., Harder, S., Fuhr, U. and Liermann, D., Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remot-control drug delivery device (HF-capsule). Am. J. Med., 87S (1989) 66-69.
151. Sutcliffe, F.A., Riley, S.A., Lynch, J., Taylor, D.C., Turnberg, L.A. and Rowland, M., Comparative absorption of drugs from jejenum and ileum of rat and human. Third Conference on Drug Absorption, Conference Abstracts, (Edimburg)), (1988) 37.
152. Tay, L.K., Dixon, F., Sostrin, M.B., Barr, W.H., Farmen, R.H. and Pittman, K.A., The site of gastrointesinal absorption of gepirone in humans. J. Clin. Pharmacol., 32 (1992) 827-832.
153. Taylor, D.C., Grundy, R. and Loveday, B., Chronic dog intestinal loop model for studying drug absorption as exemplified by B-adrenoreceptor blocking agents, atenolol and propranolol. J. Pharm. Sci., 70 (1981) 516-521.
154. Taylor, D.C., Pownall, R. and Burke, W., The absorption of B-adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity. J. Pharm. Pharmacol, 37 (1985) 280-283.
155. Taylor, D.C., Lynch, J. and Leahy, D.E., Model for intestinal permeability to drugs. In Hardy, J.G. Davis, S.S. and Wilson, C.G. (Eds.), Drug delivery to the gastrointestinal tract, Ellis Horwood Limited, Chichester, 1989, pp. 133-145.
156. Thanoo, B.C., Sunny, M.C. and Jayakrishnan, A., Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on gastric fluid. J. Pharm. Pharmacol., 45 (1993) 21-24.
157. Timmermans, J. Floating hydrophilic matrix dosage forms for oral use: factors controlling their buoyancy and gastric residence capabilities, Ph. D. Thesis, University of Brussels, 1991.
158. Timmermans, J. and Moës, A.J., How well do floating dosage forms float? Int. J. Pharm., 62 (1990) 207-216.
159. Timmermans, J. and Moës, A.J., Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. J. Pharm. Sci., 83 (1994) 18-24.
160. Triscari, J., Pan, H.Y., DeVault, A., Rossi, L.C., Jemal, M., Muldowney, R.S., O'Donnell, D.M. and Zinny, M.A., Absorption of pravastatin from various sites in the gastrointestinal tract. Clin. Pharmacol. Ther., 53 (1993) 208 (Abstract).
161. Ushimaru, K., Nakamichi, K. and Saito, H., Slow release preparation. UK Patent Application GB, 2,163,648,A (1985) 1-8.
162. Van den Mooter, G., Samyn, C. and Kinget, R., In vitro release study of ibuprofen from a colon-specific drug delivery system. Eur. J. Pharm. Biopharm., 40 (1994) 38S.
163. Van den Mooter, G., Samyn, C. and Kinget, R., In vivo evaluation of a colon-specific drug delivery system: an absorption study of theophylline from capsules coated with azo polymers in rats. Pharm. Res., 12 (1995) 244-247.
164. Vidon, N., Evard, D., Godbillon, J., Rongier, M., Duval, M., Schoeller, J.P., Bernier, J.J. and Hirtz, J., Investigation of drug absorption from the gastrointestinal tract of man:II. Metoprolol in jejenum and ileum. Br. J. Clin. Pharmac., 19 (1985) 107S-112S.
165. Vidon, N., Palma, R., Godbillon, J., Franchisseur, C., Gosset, G., Bernier, J.J. and Hirtz, J., Gastric and intestinal absorption of oxprenolol in humans. J. Clin. Pharmacol., 26 (1986) 611-615.
166. Vidon, N., Pfeiffer, A., Godbillon, J., Rongier, M., Gauron, S., Hirtz, J., Bernier, J.J. and Dubois, J.P., Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. Br. J. Clin. Pharmac., 28 (1989) 121-124.
167. Warner, P.E., Brouwer, K.L.R., Hussey, E.K., Dukes, G.E., Heizer, W.D., Donn, K.H., Davis, I.M. and Powell, J.R., Sumatriptan absorption from different regions of the human gastrointestinal tract. Pharm. Res., 12 (1995) 138-143.
168. Warrington, S.J., Barclay, S.P., John, V.A., Shotton, P.A., Wardle, H.M. and Good, W., Influence of the site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration. Br. J. Clin. Pharmac., 19 (1985) 219S-224S.
169. Wildfeuer, A., Laufen, H., Dolling, R., Pfaff, G., Hugemann, B., Knoell, H.E. and Schuster, O., Bedeutung galenischer Formen für die orale Therapie mit antianginösen Substanzen. Therapiewoche, 36 (1986) 2996-3002.
170. Wilding, I.R., Coupe, A.J. and Davis, S.S., The role of gamma-scintigraphy in oral drug delivery. Adv. Drug Del. Rev., 7 (1991a) 87-117.
171. Wilding, I.R., Davis, S.S., Hardy, J.G., Robertson, C.S., John, V.A., Powell, M.L., Leal, M., LLoyd, P. and Walker, S.M., Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers. Br. J. Clin. Pharmac., 32 (1991b) 573-579.
172. Wilding, I.R., Davis, S.S., Bakhshaee, M., Stevens, H.N.E., Sparrow, R.A. and Brennan, J., Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm. Res., 9 (1992a) 654-657.
173. Wilding, I.R., Sparrow, R.A., Davis, S.S. and Horton, R.J., The role of gastric emptying in the absorption and metabolism of nifedipine given in a modified release pellet formulation. Int. J. Pharm., 84 (1992b) 59-67.
174. Wilding, I.R., Pharmacoscintigraphic evaluation of oral delivery systems: part I. Pharm. Tech. Eur., 3 (1994) 19-26.
175. Williams, M.F., Dukes, G.E., Heizer, W., Han, Y.-H., Hermann, D.J., Lampkin, T. and Hak, L.J., Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm. Res., 9 (1992) 1190-1194.
176. Wilson, C., Washington, C. and Washington, N., Overview of epithelial barriers and drug transport. In Rubinstein, M.H. (Ed.), Physiological pharmaceutics Biological barriers to drug absorption, Ellis Harwood Limited, New York, 1989, pp. 11-20.
177. Wilson, C.G., Washington, N., Greaves, J.L., Washington, C., Wilding, I.R., Hoadley, T. and Sims, E.E., Predictive modelling of the behaviour of a controlled release buflomedil HCl formulation using scintigraphic and pharmacokinetic data. Int. J. Pharm., 72 (1991) 79-86.
178. Wilson, C.G. and Washington, N., Assessment of disintegration and dissolution of dosage forms in vivo using gamma scintigraphy. Drug Dev. Ind. Pharm., 14 (1988) 211-281.
179. Yasuhara, M., Kimura, T. and Sezaki, H., Transport characteristics of p-acetamidobenzoic acid in brush border membrane of rat small intestine. J. Pharm. Dyn., 6 (1983) 888-891.
180. Yee, S. and Amidon, G.L., Intestinal absorption mechanism of three angiotensin-converting enzyme inhibitors: quinapril, benazepril and CGS16617. Pharm. Res., 7 (1990) S155.
181. Yuen, K.H., Deshmukh, A.A., Newton, J.M., Short, M. and Melchor, R., Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled-release formulation. Int. J. Pharm., 97 (1993) 61-77.